These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21928417)

  • 1. Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism.
    Affolter A; Fruth K; Brochhausen C; Schmidtmann I; Mann WJ; Brieger J
    Head Neck; 2011 Oct; 33(10):1448-57. PubMed ID: 21928417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response.
    Drigotas M; Affolter A; Mann WJ; Brieger J
    J Oral Pathol Med; 2013 Sep; 42(8):612-9. PubMed ID: 23480207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
    Hehlgans S; Eke I; Cordes N
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased radioresistance via G12S K-Ras by compensatory upregulation of MAPK and PI3K pathways in epithelial cancer.
    Affolter A; Drigotas M; Fruth K; Schmidtmann I; Brochhausen C; Mann WJ; Brieger J
    Head Neck; 2013 Feb; 35(2):220-8. PubMed ID: 22302684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma.
    Slomiany MG; Black LA; Kibbey MM; Day TA; Rosenzweig SA
    Biochem Biophys Res Commun; 2006 Apr; 342(3):851-8. PubMed ID: 16499871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
    Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.
    Lui VW; Thomas SM; Zhang Q; Wentzel AL; Siegfried JM; Li JY; Grandis JR
    Oncogene; 2003 Sep; 22(40):6183-93. PubMed ID: 13679857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
    Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
    Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
    Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
    J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment.
    Affolter A; Schmidtmann I; Mann WJ; Brieger J
    Oncol Rep; 2013 Feb; 29(2):785-90. PubMed ID: 23232940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
    Park SW; Kim HS; Hah JW; Jeong WJ; Kim KH; Sung MW
    Anticancer Drugs; 2010 Oct; 21(9):823-30. PubMed ID: 20717005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM; Dong S; Fan M; Li JJ
    Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.